<html>
  <head>

    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
  </head>
  <body>
    <p> </p>
    <div id="toolbar" class="toolbar-container"> </div>
    <div class="container" style="--line-height: 1.6em;" dir="ltr">
      <div class="header reader-header reader-show-element"> <a
          class="domain reader-domain"
          href="https://orinocotribune.com/covid-19-big-pharmas-obscene-profits/">orinocotribune.com</a>
        <h1 class="reader-title">COVID-19: Big Pharma’s ‘Obscene’
          Profits</h1>
        By Jake Johnson – Nov 18, 2021</div>
      <div class="content">
        <div class="moz-reader-content reader-show-element">
          <div id="readability-page-1" class="page">
            <div>
              <p><font size="4"><strong>Moderna, Pfizer and BioNTech
                    rake in millions an hour while refusing to share
                    manufacturing recipes with low-income countries.</strong></font></p>
              <p>Moderna, Pfizer and BioNTech — the makers of the two
                most successful coronavirus vaccines — are raking in a
                combined $65,000 in profits every minute as they refuse
                to share their manufacturing recipes with <a
href="https://www.nytimes.com/interactive/2021/10/22/science/developing-country-covid-vaccines.html">developing
                  countries</a>, where billions of people still lack
                access to lifesaving shots.</p>
              <p>According to a new People’s Vaccine Alliance <a
href="https://www.oxfam.org/en/press-releases/pfizer-biontech-and-moderna-making-1000-profit-every-second-while-worlds-poorest">analysis</a> of
                recent earnings reports, People’s Vaccine Alliance,  “It
                is obscene that just a few companies are making millions
                of dollars in profit every single hour while just two
                percent of people in low-income countries have been
                fully vaccinated against coronavirus,” said Maaza Seyoum
                of the People’s Vaccine Alliance Africa.</p>
              <p>“Pfizer, BioNTech, and Moderna have used their
                monopolies to prioritize the most profitable contracts
                with the richest governments, leaving low-income
                countries out in the cold.”</p>
              <p><a
href="https://orinocotribune.com/pfizer-prioritizes-profits-over-people-refuses-to-release-covid-19-vaccine-patent/"
                  target="_blank" rel="noopener">RELATED CONTENT: Pfizer
                  Prioritizes Profits over People, Refuses to Release
                  COVID-19 Vaccine Patent</a></p>
              <p>Moderna — a Massachusetts-based company that developed
                its vaccine with the help of <a
href="https://www.commondreams.org/news/2021/11/11/nih-praised-finally-showing-modicum-verve-vaccine-patent-fight-moderna">government
                  research</a> and around $10 billion in taxpayer
                funding — has delivered just 0.2 percent of its total
                vaccine supply to low-income countries, the People’s
                Vaccine Alliance estimates. The coronavirus vaccine is
                Moderna’s only product on the market.</p>
              <p>Pfizer and its Germany-based partner BioNTech — whose
                vaccine was also <a
href="https://www.bloomberg.com/news/articles/2020-11-09/pfizer-vaccine-s-funding-came-from-berlin-not-washington">helped
                  along</a> by taxpayer money — haven’t done much better
                than their competitor, sending less than 1 percent of
                their supply to poor nations while profiting hugely from
                sales to rich countries.</p>
              <p>“Predominantly, right now, we have already signed
                orders, and those are with high-income countries,”
                Pfizer CEO Albert Bourla recently <a
href="https://www.barrons.com/articles/pfizer-covid-earnings-ceo-51635884114">said</a> of
                coronavirus vaccine sales for next year, blaming poor
                countries for not ordering shots quickly enough.</p>
              <p>“We are negotiating right now with few middle-income
                countries, and with even fewer low-income countries,”
                Bourla said.</p>
              <p>But public health campaigners argue that bilateral
                deals and vaccine donations are not sufficient to bring
                production and distribution into line with global needs.
                Instead, they say, pharmaceutical giants must relinquish
                their vaccine recipes and allow <a
href="https://www.nytimes.com/interactive/2021/10/22/science/developing-country-covid-vaccines.html">qualified
                  manufacturers</a> around the world to produce low-cost
                generic versions for their populations.</p>
              <p><a
href="https://orinocotribune.com/bad-intentions-us-sanctions-iranian-pharmaceutical-company-developing-anti-covid-vaccine/"
                  target="_blank" rel="noopener">RELATED CONTENT: Bad
                  Intentions: US Sanctions Iranian Pharmaceutical
                  Company Developing Anti-COVID Vaccine</a></p>
              <p>Moderna and Pfizer-BioNTech have thus far refused to do
                so — and <a
href="https://www.bloomberg.com/graphics/2021-pfizer-secret-to-whats-in-the-covid-vaccine/">lobbied
                  aggressively</a> against a World Trade Organization
                proposal to temporarily suspend vaccine patents. Bourla,
                for his part, has dismissed technology-transfer
                proposals as “dangerous nonsense.”</p>
              <p>“Contrary to what Pfizer’s CEO says, the real nonsense
                is claiming the experience and expertise to develop and
                manufacture lifesaving medicines and vaccines does not
                exist in developing countries,” Anna Marriott, health
                policy manager at Oxfam International, <a
href="https://www.oxfam.org/en/press-releases/pfizer-biontech-and-moderna-making-1000-profit-every-second-while-worlds-poorest">said</a> in
                a statement Tuesday. “This is just a false excuse that
                pharmaceutical companies are hiding behind to protect
                their astronomical profits.”</p>
              <p>“It is also a complete failure of government to allow
                these companies to maintain monopoly control and
                artificially constrain supply in the midst of a pandemic
                while so many people in the world are yet to be
                vaccinated,” she added.</p>
              <p>(<a
href="https://consortiumnews.com/2021/11/18/covid-19-big-pharmas-obscene-profits/"
                  target="_blank" rel="noopener">Consortium News</a>)</p>
              <div data-profile-layout="layout-1"
                data-author-ref="guest-13030" id="mab-1068580613"
                data-plugin-release="4.3.12" data-plugin-version="free"
                data-box-layout="slim" data-box-position="below"
                data-multiauthor="false" data-author-type="guest"
                itemscope="" itemtype="https://schema.org/Person">
                <div>
                  <div itemprop="description">
                    <p>Jake Johnson is a staff writer for Common Dreams.</p>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div> </div>
    </div>
  </body>
</html>